V12 SENTINEL ENGINE · AI MARKET ANALYSIS
Row
T
TAKAI Stock Diagnostic Report

Form 144 Takeda Pharmaceutical Company Limited For: 13 July

The submission of Form 144 by Takeda Pharmaceutical indicates the intention of insiders to sell shares, reflecting a general change in equity rather than a fundamental business shift for the company.

View Source Article ↗
AI CATALYST SCORE20 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time
+
ANALYSIS HISTORY

TAK Analysis History (Last 30 Days)

Diagnosed AtTickerAI ScoreTier
2026-08-28 22:58:10TAK85MidView Report →
2026-08-28 21:48:20TAK75MidView Report →
2026-07-30 06:55:30TAK50RowView Report →
View Full History for TAK (Blueprint) →